During the COVID-19 pandemic, there have been many proposed medications that may be used to help treat this virus. One such medication is chloroquine/hydroxychloroquine [Fig. 1](#fig0001){ref-type="fig"} . Numerous institutions are currently studying these drugs to see their efficacy in the treatment of COVID-19. These notes are to help in guiding the diagnosis/management of overdoses of this medication.Fig. 1Representative bottle of hydroxychloroquine tablets.Fig 1

These are antimalarial drugs that are also used for autoimmune diseases such as rheumatoid arthritis and lupus[@bib0001], [@bib0002].

Mechanism of action {#sec0001}
===================

•Block the synthesis of DNA and RNA and have some quinidine like cardiotoxicity•Chloroquine is 2-3 times more toxic than hydroxychloroquine•Sodium and potassium channel blockade are proposed mechanisms of cardiovascular collapse

Toxic dose {#sec0002}
==========

Therapeutic dose of chloroquine {#sec0003}
-------------------------------

•Prophylaxis for malaria- 500 mg/week for prophylaxis•Treatment of malaria 2.5 gm over 2 days•Reports of deaths in children after ingestion of 1-2 tabs.•Lethal dose in adult \~30--50 mg/kg

Clinical Presentation {#sec0004}
=====================

Symptom onset is rapid usually within 30 min, death within 1--3 hours usually from cardiac arrest[@bib0001], [@bib0002] [@bib0003].

Mild to moderate {#sec0005}
----------------

•Dizziness, nausea/vomiting, abdominal pain, headache, visual/retinal disturbances, auditory disturbances, agitation, neuromuscular excitability.•Can cause hemolysis in G6PD deficiency, rarely causes retinal damage, sensorineural deafness, hypoglycemia.

Severe {#sec0006}
------

•Convulsions, coma, shock, respiratory/cardiac arrest[@bib0001], [@bib0002].•Quinidine-like cardiotoxicity- Sino-atrial node arrest, depressed myocardial contractility, QRS and/or QTc prolongation, heart block, ventricular arrythmias, ST and T wave depression, u waves. Hypokalemia can occur and contribute to dysrhythmias[@bib0003].

Clinical criteria associated with fatal outcome[@bib0003] {#sec0007}
---------------------------------------------------------

•Ingestion of greater than 5 gm[@bib0002].•Systolic BP \<80 mm/Hg.•Prolongation of QRS longer than 120 msec.•Ventricular rhythm disturbances.•Blood concentrations \>8 mcg/ml.

Diagnosis/Treatment {#sec0008}
===================

•Early intubation/mechanical ventilation for significant ingestions/symptoms due to seizure risk/airway protection[@bib0003].•Electrolytes, glucose, BUN, creatinine, EKG and tele-monitoring.•Treatment of QRS prolongation with sodium bicarbonate is controversial. Be mindful that alkalinization can further exacerbate hypokalemia---before using sodium bicarbonate assess the full clinical picture specifically cardiac toxicity and degree of hypokalemia[@bib0003].•K repletion for *severe* hypokalemia (usually due to intracellular shift not overall potassium deficit)---dose with caution and frequent potassium checks as redistribution of potassium may cause a rebound hyperkalemia and may worsen cardiotoxicity[@bib0003].•Hypokalemia correlates with severity of ingestion and occurs within a few hours of ingestion.•Vasopressor support for hypotension not responsive to fluids.•Hypotension is multifactorial→•distributive from hydroxychloroquine/chloroquine induced vasodilation,[@bib0002]•bradycardia from negative ionotropic effect[@bib0002]•cardiogenic effects from direct cardiotoxicity[@bib0002]•Studies done with use of epinephrine (first line treatment)---0.25 mcg/kg/min and increase by 0.25 mcg/kg/min until adequate BP (\~100 mmhg)---again monitor potassium as this can further cause intracellular shift[@bib0001], [@bib0002].•High dose benzos---studies done with diazepam 2mg/kg IV over 30 min after intubation then 1-2 mg/kg/day[@bib0001], [@bib0002].•Avoid type 1A anti-arrhythmics.•Extracorporeal removal methods have not been shown to be useful---as hydroxychloroquine/chloroquine have large volume of distribution and significant protein binding[@bib0003].•Questionable benefit from lipid emulsion therapy---there are a few case reports that have demonstrated improvement in patients that have overdosed on these medications[@bib0004].
